Humans are infected by common serotypes of
human adenovirus such as AdHu5 and a significant percentage has neutralizing antibodies to this serotypes, which impair the efficacy of AdHu5 based vaccines.
Not exact matches
Furthermore, severe infections from
human adenoviruses are more commonly associated with older age, immunosuppression, and chronic underlying conditions
such as kidney failure [4], [41].
Some serotypes,
such as
human adenovirus type 14 (HAdV - 14), have been associated with severe and potentially fatal outbreaks of pneumonia in residential facilities and military bases [4].
The facility routinely produces
human and primate
Adenovirus (Ad) and MVA vectors and its capability will soon expand to include other viral vector backbones,
such as adeno - associated virus (AAV).
Such antibodies are expected to reduce the efficacy of vaccines based on common
human serotypes of
adenovirus in a
human target population.